You searched for "complication"
Report on ‘2024: Artificial Intelligence and the Eye’
3 June 2024
| Somain Verma
|
EYE - General
As the application of artificial intelligence (AI) is brought to the foray of clinical medicine, you can be forgiven for thinking that it is a relatively recent technology. However, researchers and computer scientists have been working on it for many...
Ocular bubbly: a vitreoretinal update on the art of gases
5 April 2022
| Adonis El Salloukh, Alexander Chiu, Sidath Wijetilleka
|
EYE - Vitreo-Retinal, EYE - General
The authors remind us of the revolutionary impact gases have had on retinal surgery. In 1938, Rosengren attempted to improve his retina repair surgical outcomes [1]. He discovered that suturing the retina or pressing externally on the sclera were not...
Winner Announcement - Glaucoma UK ‘Excellence in Glaucoma Care Award 2023’
10 May 2023
|
glaucoma uk, award
Dr Sancy Low, Consultant Ophthalmic Surgeon at Guy’s and St Thomas’ NHS Foundation Trust, wins the Glaucoma UK ‘Excellence in Glaucoma Care Award 2023’.
Phaco-ECP vs. Phaco alone to treat glaucoma
1 December 2015
| Anjali Gupta
|
EYE - Glaucoma
This retrospective review compared combined phacoemulsification and endoscopic cyclophotocoagulation (phaco-ECP) to phaco alone in patients with mild to moderate glaucoma. Outcome measures included cumulative full and qualified success survival, postintervention IOP and ocular anti-hypertensive medication reduction. Full success was defined...
Practice Plus Group: Cataract - from referral to discharge
5 June 2025
Practice Plus Group is delighted to offer an accredited event for local referrers: ‘Cataract – from referral to discharge’ Discussion on local cataract acceptance criteria and the ideal patient journey from assessment to discharge. The workshop will cover a range...
Management of diffuse OSSN with topical chemotherapy
Ocular surface squamous neoplasia (OSSN) can be localised to the conjunctiva or, less commonly, diffusely spread over the conjunctiva and cornea. Localised OSSN can be treated by surgical removal with adjuvant cryotherapy and chemotherapy with low rates of recurrence. Diffuse...
Atropine penalisation for amblyopia in the UK
The authors aimed to determine the current clinical practice of atropine penalisation (AP) in the UK, to identify perceived barriers limiting use of AP as a first line treatment and ascertain whether any of the barriers could be resolved. An...
Diagnostic procedures in vitreoretinal lymphoma.
1 December 2014
| Nikolaos D Georgakarakos
|
EYE - Vitreo-Retinal
This paper presented a retrospective review of medical records of HIV negative immunocompetent patients diagnosed with vitreoretinal lymphoma between 1994 and 2012. The aim of the paper was to evaluate the type and number of diagnostic interventions required to confirm...
Clinical outcomes of endoscopic dacryocystorhinostomy
The aim of this study was to report the authors’ experience with endoscopic dacryocystorhinostomy (ED) in a paediatric population and to evaluate the effect of surgical site reassessment on anatomy and clinical outcomes. The study included 47 children <18 years...
Risk factors and management for postoperative complications in strabismus surgery
This retrospective cohort study examined 1273 patients, comprising 1035 cases of exotropia and 238 cases of esotropia, with a minimum 18-month follow-up after strabismus surgery. Baseline demographics, age at surgery, pre / postoperative visual acuity, and deviation were included. Complications...
Transient thickening of the macular retinal nerve fibre layer in acute optic neuritis
1 December 2022
| Claire Howard
|
EYE - Neuro-ophthalmology
|
Optic neuritis, axonal degeneration, neurofilament protein, retina, tissue
Acute optic neuritis (ON) causes axonal degeneration, which can be quantified from the blood by neurofilament protein (Nf) levels. Within about three months, atrophy of the retinal nerve fibre layer (RNFL) follows. However, it remains challenging to explain why there...
